Artificial intelligence has become the most commercially active area of diagnostic imaging innovation. AI algorithms for chest X-ray triage, CT pulmonary embolism detection, mammography cancer detection, brain MRI stroke assessment, and dozens of other clinical applications are being cleared by the FDA and CE marked in Europe at an accelerating pace. Every major OEM has embedded AI across its product portfolio — GE HealthCare's Edison platform, Siemens Healthineers' AI-Rad Companion, Philips's IntelliSpace AI, and Fujifilm's REiLI ecosystem represent the four major AI platform strategies.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• AI Algorithm Regulatory Clearances
• OEM AI Platform Comparison
• Radiology Workflow AI
• AI Triage and Prioritization
• Computer-Aided Detection and Diagnosis
• AI in Mammography
• AI Business Models — Embedded vs. Marketplace
• Startup Ecosystem
Table of Contents
1. Executive Summary
2. Market Overview
3. AI Algorithm Regulatory Clearances
4. OEM AI Platform Comparison
5. Radiology Workflow AI
6. AI Triage and Prioritization
7. Computer-Aided Detection and Diagnosis
8. AI in Mammography
9. AI Business Models — Embedded vs. Marketplace
10. Startup Ecosystem
11. Competitive Landscape
12. Regional Market Analysis
13. Strategic Conclusions and Recommendations
14. Appendix
List of Tables
Table 1. Market Overview and Key Data 2025
Table 2. Competitive Landscape 2025
Table 3-8. Topic-Specific Analysis Tables
Table 3. Leading Companies — Portfolio and Strategy Assessment 2025
Table 4. M&A and Partnership Activity 2023-2025
Table 5. Regional Analysis
Table 6. Key Risks and Mitigation Strategies
Companies Profiled
Aidoc
Canon Medical
GE HealthCare
Intelerad
Nuance
Philips
Siemens Healthineers
Viz.ai
